Vanguard Group
TSRX

Vanguard Group’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Vanguard Group’s Portfolio TSRX Stock Details TSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-659,415
Closed -$5.36M – 3856
2013
Q2 		$5.36M Buy
+659,415
New +$5.36M ﹤0.01% 2624